AAPL   317.86 (+0.36%)
MSFT   179.09 (-1.37%)
AMZN   2,395.66 (-1.08%)
NVDA   338.55 (-2.91%)
CGC   20.32 (+1.55%)
BABA   200.85 (-0.44%)
MU   45.85 (+0.11%)
TSLA   817.77 (-0.13%)
AMD   52.31 (-1.65%)
T   31.60 (+2.50%)
ACB   15.74 (+0.83%)
F   6.06 (+3.77%)
DIS   123.53 (+2.13%)
BAC   25.62 (+5.48%)
AAPL   317.86 (+0.36%)
MSFT   179.09 (-1.37%)
AMZN   2,395.66 (-1.08%)
NVDA   338.55 (-2.91%)
CGC   20.32 (+1.55%)
BABA   200.85 (-0.44%)
MU   45.85 (+0.11%)
TSLA   817.77 (-0.13%)
AMD   52.31 (-1.65%)
T   31.60 (+2.50%)
ACB   15.74 (+0.83%)
F   6.06 (+3.77%)
DIS   123.53 (+2.13%)
BAC   25.62 (+5.48%)
AAPL   317.86 (+0.36%)
MSFT   179.09 (-1.37%)
AMZN   2,395.66 (-1.08%)
NVDA   338.55 (-2.91%)
CGC   20.32 (+1.55%)
BABA   200.85 (-0.44%)
MU   45.85 (+0.11%)
TSLA   817.77 (-0.13%)
AMD   52.31 (-1.65%)
T   31.60 (+2.50%)
ACB   15.74 (+0.83%)
F   6.06 (+3.77%)
DIS   123.53 (+2.13%)
BAC   25.62 (+5.48%)
AAPL   317.86 (+0.36%)
MSFT   179.09 (-1.37%)
AMZN   2,395.66 (-1.08%)
NVDA   338.55 (-2.91%)
CGC   20.32 (+1.55%)
BABA   200.85 (-0.44%)
MU   45.85 (+0.11%)
TSLA   817.77 (-0.13%)
AMD   52.31 (-1.65%)
T   31.60 (+2.50%)
ACB   15.74 (+0.83%)
F   6.06 (+3.77%)
DIS   123.53 (+2.13%)
BAC   25.62 (+5.48%)
Log in

Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 Sutro BiopharmaGritstone OncologyAutolus TherapeuticsNantkwestADMA Biologics
SymbolNASDAQ:STRONASDAQ:GRTSNASDAQ:AUTLNASDAQ:NKNASDAQ:ADMA
Price Information
Current Price$9.73$6.51$12.01$5.45$2.97
52 Week RangeBuyBuyBuySellBuy
Beat the Market™ Rank
Overall Score2.11.61.40.82.2
Analysis Score3.43.53.50.53.4
Community Score2.42.72.42.63.0
Dividend Score0.00.00.00.00.0
Ownership Score4.01.01.01.04.0
Earnings & Valuation Score0.60.60.00.00.6
Analyst Ratings
Consensus RecommendationBuyBuyBuySellBuy
Consensus Price Target$18.67$17.00$22.67$1.00$7.40
% Upside from Price Target91.85% upside161.14% upside88.73% upside-81.65% downside149.58% upside
Trade Information
Market Cap$228.57 million$242.56 million$463.69 million$549.68 million$253.87 million
Beta0.421.481.962.842.03
Average Volume129,036183,675113,8631,047,0212,634,771
Sales & Book Value
Annual Revenue$42.74 million$4.36 million$2.91 million$40,000.00$29.35 million
Price / Sales5.2955.63165.7013,421.998.72
CashflowN/AN/AN/AN/AN/A
Price / CashN/AN/AN/AN/AN/A
Book Value$3.53 per share$3.10 per share$7.16 per share$1.04 per share$1.12 per share
Price / Book2.762.101.685.242.65
Profitability
Net Income$-55,740,000.00$-94,430,000.00$-123,850,000.00$-65,790,000.00$-48,280,000.00
EPS($2.43)($2.81)($2.88)($0.70)($0.92)
Trailing P/E RatioN/AN/AN/AN/AN/A
Forward P/E RatioN/AN/AN/AN/AN/A
P/E GrowthN/AN/AN/AN/AN/A
Net Margins-148.06%-2,397.90%-9,870.67%-112,350.85%-151.18%
Return on Equity (ROE)-59.70%-69.76%-45.59%-51.94%-105.97%
Return on Assets (ROA)-36.43%-52.35%-38.88%-43.75%-35.21%
Dividend
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity Ratio0.29%0.17%0.08%0.10%1.02%
Current Ratio3.98%6.09%10.78%3.10%11.90%
Quick Ratio3.98%6.09%10.78%3.10%8.14%
Ownership Information
Institutional Ownership Percentage51.10%77.62%38.12%6.19%56.12%
Insider Ownership Percentage14.50%22.70%N/A72.08%15.20%
Miscellaneous
Employees141113N/A161314
Shares Outstanding23.23 million37.26 million40.15 million98.51 million86.35 million
Next Earnings Date8/12/2020 (Estimated)8/10/2020 (Estimated)N/A8/4/2020 (Estimated)8/13/2020 (Estimated)
OptionableNot OptionableNot OptionableNot OptionableOptionableOptionable

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.